Articles

Results 1 to 5 of 9


Essential oils are a staple commercial product, says Full Court

Australia - May 9 2022 A recent Full Federal Court decision has discussed the meaning of the term “staple commercial product” within the context of patent infringement by…

Full Court confirms relevant regulatory approval date for PTE

Australia - April 4 2022 The Full Federal Court has confirmed that the relevant regulatory approval date for requesting a pharmaceutical patent term extension (PTE) is the…

High Court confirms only patentees can bring infringement proceedings during the extended term of a pharmaceutical patent

Australia - March 9 2022 Pharmaceutical patent term extensions (PTE) are a highly litigated area of patent law. Australia’s longest running PTE litigation relates to a patent…

Inspire Issue 51- December 2021

Australia - December 16 2021 Many of us have been living and working with a heightened sense of uncertainty for the past two years. Uncertainty can however offer a chance at a…

Danielle Burns, Adrian Crooks, Alexis Keating, Jacqueline Leong, Ross McFarlane

Reporting burdens imposed by Section 76A have been repealed

Australia - December 10 2018 Recent legislative changes have removed a reporting burden from patentees applying for pharmaceutical extensions of term. Section 76A of the…